FUROSCIX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Furoscix, and when can generic versions of Furoscix launch?
Furoscix is a drug marketed by Scpharmaceuticals and is included in one NDA. There are three patents protecting this drug.
This drug has twenty-four patent family members in fifteen countries.
The generic ingredient in FUROSCIX is furosemide. There are twenty-two drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the furosemide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Furoscix
A generic version of FUROSCIX was approved as furosemide by MYLAN on October 29th, 1986.
Summary for FUROSCIX
International Patents: | 24 |
US Patents: | 3 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 137 |
Clinical Trials: | 2 |
Patent Applications: | 3,937 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for FUROSCIX |
What excipients (inactive ingredients) are in FUROSCIX? | FUROSCIX excipients list |
DailyMed Link: | FUROSCIX at DailyMed |
Recent Clinical Trials for FUROSCIX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Texas Southwestern Medical Center | Phase 2 |
scPharmaceuticals, Inc. | Phase 2 |
scPharmaceuticals, Inc. | Phase 1 |
Pharmacology for FUROSCIX
Drug Class | Loop Diuretic |
Physiological Effect | Increased Diuresis at Loop of Henle |
Anatomical Therapeutic Chemical (ATC) Classes for FUROSCIX
US Patents and Regulatory Information for FUROSCIX
FUROSCIX is protected by three US patents.
Patents protecting FUROSCIX
Pharmaceutical formulations for subcutaneous administration of furosemide
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Pharmaceutical formulations for subcutaneous administration of furosemide
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: USE OF A LIQUID FORMULATION COMPRISING FUROSEMIDE TO TREAT CONGESTION DUE TO FLUID OVERLOAD (EDEMA) IN ADULTS WITH NYHA CLASS II/III CHRONIC HEART FAILURE
Pharmaceutical formulations for subcutaneous administration of furosemide
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: USE OF A LIQUID FORMULATION COMPRISING FUROSEMIDE TO TREAT CONGESTION DUE TO FLUID OVERLOAD (EDEMA) IN ADULTS WITH NYHA CLASS II/III CHRONIC HEART FAILURE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scpharmaceuticals | FUROSCIX | furosemide | SOLUTION;SUBCUTANEOUS | 209988-001 | Oct 7, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Scpharmaceuticals | FUROSCIX | furosemide | SOLUTION;SUBCUTANEOUS | 209988-001 | Oct 7, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Scpharmaceuticals | FUROSCIX | furosemide | SOLUTION;SUBCUTANEOUS | 209988-001 | Oct 7, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for FUROSCIX
See the table below for patents covering FUROSCIX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
World Intellectual Property Organization (WIPO) | 2014165660 | ⤷ Try a Trial | |
Mexico | 367165 | FORMULACIONES FARMACÉUTICAS PARA ADMINISTRACIÓN SUBCUTÁNEA DE FUROSEMIDA. (PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION OF FUROSEMIDE.) | ⤷ Try a Trial |
Singapore | 10201709388Q | PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION OF FUROSEMIDE | ⤷ Try a Trial |
Japan | 6677779 | ⤷ Try a Trial | |
South Korea | 20160014592 | 퓨로세마이드의 피하 투여용 약학 제형 (PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION OF FUROSEMIDE) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |